Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 01.12.2025
HausVorteil AG
Company Name:
HausVorteil AG
ISIN:
DE000A31C222
Reason for the research:
INITIAL STUDY ‘Equity Release’
Recommendation:
Buy
from:
01.12.2025
Target price:
31.00 Euro
Target price on sight of:
12 month
Last rating change:
None
Analyst:
René Parmantier, Benedikt Krämer
Scalable equity release business mode [ … ]
Mon, 17.11.2025
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update
Recommendation:
Buy
from:
17.11.2025
Target price:
35.00 Euro
Target price on sight of:
12 month
Last rating change:
none
Analyst:
Daniel Großjohann, Thomas Schießle
Q3: Adjusted EBITA exceeds market expectations, market environme [ … ]
Tue, 30.09.2025
CLINUVEL Pharmaceuticals Limited
Company Name:
CLINUVEL Pharmaceuticals Limited
ISIN:
AU000000CUV3
Reason for the research:
Update
Recommendation:
Buy
from:
30.09.2025
Target price:
26.50 AU$
Target price on sight of:
12 month
Last rating change:
none
Analyst:
Thomas Schiessle, Daniel Großjohann
CLINUVEL strengthens global position with tariff advantage [ … ]
Mon, 23.06.2025
CLINUVEL Pharmaceuticals
Company Name:
CLINUVEL Pharmaceuticals
ISIN:
AU000000CUV3
Reason for the research:
Research Update
Recommendation:
Buy
from:
23.06.2025
Target price:
22.00 AU$
Target price on sight of:
12 month
Last rating change:
none
Analyst:
Thomas Schiessle, Daniel Großjohann
CEO Dr. Philippe Wolgen back on board – SCENESSE® [ … ]
Mon, 19.05.2025
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update Q1 2025
Recommendation:
Buy
from:
19.05.2025
Target price:
32,25 Euro
Target price on sight of:
12 month
Last rating change:
no change
Analyst:
Daniel Großjohann, Thomas Schießle
Q1 2025 impacted by economic environment – indirec [ … ]
Fri, 07.03.2025
CLINUVEL Pharmaceuticals
Company Name:
CLINUVEL Pharmaceuticals
ISIN:
AU000000CUV3
Reason for the research:
Update
Recommendation:
BUY
from:
07.03.2025
Target price:
22 AU$
Target price on sight of:
12 month
Last rating change:
no change
Analyst:
Thomas Schiessle, Daniel Großjohann
H1/25 with another record result - more speed + higher opportunit [ … ]
Mon, 18.11.2024
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update Q3 2024
Recommendation:
Buy
from:
18.11.2024
Target price:
34.30
Target price on sight of:
12 month
Last rating change:
no change
Analyst:
Daniel Großjohann, Thomas Schießle
2024 guidance after Q3 confirmed in key points, public share [ … ]
